PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort
PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort
Not yet recruiting · NCT07560215 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Not yet recruiting | Not stated | 2026-05-01 | NCT07560215 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||